患者报告的药物过敏与全髋/膝关节置换术后假体周围感染及功能结局的关联
该回顾性研究纳入单中心10年内31109例初次择期全髋或全膝关节置换患者,发现报告过敏数每增加1种,假体周围感染翻修风险增加1.11倍,但过敏数不影响3个月或1年功能结局评分。
要点
- 报告过敏数每增加1种,PJI翻修风险增加1.11倍(95%CI 1.07-1.14,P<.0001)。
- 因感染翻修者报告过敏数显著高于未翻修者(1.68±1.9 vs 1.23±1.9,P<.0005)。
- 患者报告过敏数未预测3个月或1年功能结局评分。
核心结论
- 报告过敏数较多的患者在全关节置换术后可能面临更高的假体周围感染风险。
- 患者报告过敏数与术后3个月或1年功能结局评分无关。
研究设计与样本
- 单中心回顾性研究,纳入10年间所有初次择期全髋或全膝关节置换患者。
- 共分析31109例患者,收集人口学、临床信息及患者报告过敏数和类型。
- 采用单变量和多变量logistic回归分析PJI危险因素,单变量分析评估过敏数与功能结局的关系。
主要发现
- 31109例中941例(3%)因感染行翻修(膝491例,髋450例)。
- 16435例(52.8%)报告至少1种过敏,平均过敏数1.2±1.9。
- 因感染翻修者报告过敏数显著更高(1.68±1.9 vs 1.23±1.9,P<.0005,95%CI -0.58至0.33)。
- 单变量回归中过敏数独立预测感染翻修(P<.0001),年龄、性别、BMI和吸烟状态亦为预测因素。
- 多变量回归中每增加1种报告过敏,PJI风险增加1.11倍(95%CI 1.07-1.14,P<.0001)。
临床怎么用
- 术前可采集患者报告的药物过敏数量,作为PJI风险的辅助评估信息。
- 对报告多种药物过敏的患者,可加强术后感染监测与预防措施。
- 不应依据过敏数预测或干预术后功能康复。
局限性
- 研究为单中心回顾性设计,证据等级为预后II级。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The purpose of this study is to determine if the number and types of patient-reported drug allergies are associated with prosthetic joint infection (PJI) and functional outcomes following total joint arthroplasty (TJA). METHODS: This is a retrospective review of all patients who underwent a primary, elective total hip (THA) or knee arthroplasty (TKA) over a 10-year period at a single academic institution. Demographic, clinical information, and number and type of patient-reported drug allergy was collected. Univariate and multivariate logistic regressions were performed to identify risk factors for PJI and risk of PJI based on number of allergies. Univariate analysis was also performed to identify if the number of patient-reported allergies affected functional outcome scores. RESULTS: Of 31,109 patients analyzed, there were 941 (3%) revisions for infection (491 knees and 450 hips). At least one allergy was reported by 16,435 (52.8%) patients, with a mean of 1.2 ± 1.9. Those who underwent revision for infection had a significantly higher number of reported allergies (1.68 ± 1.9 vs 1.23 ± 1.9, P < .0005, 95% confidence interval -0.58 to 0.33). On univariate regression the number of allergies independently predicted revision TJA for infection (P < .0001) as did age, gender, body mass index, and smoking status. On multivariate regression for each additional patient-reported allergy, risk of PJI increased by 1.11 times (95% confidence interval 1.07-1.14, P < .0001). Number of patient-reported allergies did not predict 3-month or 1-year functional outcome scores. CONCLUSION: Patients with a higher number of reported allergies may be at increased risk of PJI following TJA. LEVEL OF EVIDENCE: Prognostic Level II.
引用
- Fisher ND, Bi AS, Singh V, et al. Are Patient-Reported Drug Allergies Associated With Prosthetic Joint Infections and Functional Outcomes Following Total Hip and Knee Arthroplasty? J Arthroplasty. 2021. PMID: 34547427. doi:10.1016/j.arth.2021.09.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。